8-Amino-7-hydroxy-4-methyl-chromen-2-one, 95.0%, 500mg

N-(4-Nitro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide, 95.0%, 5g

6-Hydroxypyridazine-3-carbaldehyde, 95.0%, 1g

(4,6-Dichloropyridin-3yl)boronic acid, 95.0%, 1g

(2R,3S)-2-(4-(cyclopentylamino)phenyl)-1-(2-fluoro-6-methylbenzoyl)piperidine-3-carboxylic acid, 97%, 250mg

N-(1-Naphthyl)-ethylenediamine, dihydrochloride min. 99%, pa, 25 g, glass packaging

5-Ethylpyridine-2,3-dicarboxylic Acid>98.0%(GC)(T)5g

N-(1,3-benzodioxol-5-ylmethyl)-2-cyanoacetamide, 10g

2',4'-Difluoro-[1,1'-biphenyl]-4-ol, 98%, 100mg

TERT-BUTYL N-[2-OXO-1-PHENYL-2-(PYRROLIDIN-1-YL)ETHYL]CARBAMATE, 95.0%, 500mg

3,5-Difluoro-4-iodo-pyridine, 98.0%, 250mg

PHENYL 2-ETHYLBUTANOATE, 95%, 1g

2-(5-Chloro-4-methylthiophen-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 96%, 250mg